Noveko International Announces a Private Placement of approximately C$10 million

    Symbol: EKO / TSX

    MONTREAL, Sept. 4 /CNW Telbec/ - Noveko International Inc. ("the
Company") is pleased to announce that it has entered into an agreement with
Desjardins Securities Inc. as lead Agent on behalf of a syndicate
(collectively "the Agents") to raise approximately C$10 million of Units (the
"Units") by way of a best efforts private placement (the "Offering"). Each
Unit will consist of one Class A Share of the Company and one-half of one
Class A Share purchase warrant. The Units will be priced in the context of the
    The Units will be offered to qualified investors in each province of
Canada and potentially in other jurisdictions pursuant to applicable private
placement exemptions. The securities issued pursuant to the Offering will be
subject to a 4 month hold period. The Offering will be subject to the usual
conditions, and the receipt of all required regulatory approvals, including
approval of the Toronto Stock Exchange.
    The securities offered have not been registered, and will not be,
registered under the United States Securities Act of 1933, as amended, and may
not be offered or sold in the United States absent registration or an
applicable exemption from the registration requirements.
    The net proceeds of the Offering will be used to pursue the Company's
global growth objectives, namely, fund the expansion of its international
distribution networks, develop its current IP portfolio, develop new
innovative applications, expand its production capacity, and for working
capital purposes.
    This press release does not constitute an offer to sell or the
solicitation of any offer to buy nor will there be any sale of these
securities in any province, state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such province, state or jurisdiction.


    Noveko International Inc. offers innovative solutions in the
environmental and medical fields worldwide. Through its subsidiaries, the
Company specializes primarily in the following business segments: the
development, manufacturing and marketing of derivative products from its
patented antimicrobial filtration technology, including air filters, surgical
masks and respirators, along with other products with antimicrobial properties
such as AZURO(TM) hand sanitizers - and the development, manufacturing and
marketing of medical equipment, primarily portable real-time ultrasound
scanners for use in human and veterinary medicine.

    Certain statements set forth in this press release constitute
forward-looking statements. In some cases, these statements are identified by
the use of terms such as "may", "could", "might", "intend", "should",
"expect", "project", "plan", "believe", "estimate" or other comparable
variants. These statements are based on the information available at the time
they are written, on assumptions made by management and on the expectations of
management, acting in good faith, regarding future events, including those
relating to economic conditions, fluctuations in exchange rates and operating
expenses, and the absence of unusual events entailing supplementary
expenditures. Although management considers these assumptions and expectations
reasonable based on the information available at the time they are written,
they could prove inaccurate. Forward-looking statements are also subject, by
their very nature, to known and unknown risks and uncertainties such as those
related to the industry, acquisitions, labor relations, credit, key officers,
supply and product liability. The actual results of Noveko International Inc.
could differ materially from those indicated or underlying these
forward-looking statements. The reader is therefore recommended not to unduly
rely on these forward-looking statements. Forward-looking statements do not
reflect the potential impact of special items, any business combination or any
other transaction that may be announced or occur subsequent to the date
hereof. The Company undertakes no obligation to update or revise the
forward-looking statements to account for new events or new circumstances,
except where provided for by applicable legislation.

For further information:

For further information: Chantal Vennat, Director, Investor Relations
and Corporate Communications, Noveko International Inc., (514) 875-0606;

Organization Profile

Noveko International Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890